proteolysis. Asp-Glu-Val-Asp-ase activity was detectable in endothelial cells after 4 h of treatment with adenosine-homocysteine. The PTPase inhibitor sodium orthovanadate did not prevent endothelial cell retraction or FAK, paxillin, or vinculin redistribution. Sodium orthovanadate did block adenosine-homocysteine-induced FAK, paxillin, and p130 CAS proteolysis and Asp-Glu-Val-Asp-ase activity. Thus disruption of focal adhesion contacts and caspase-induced degradation of focal adhesion contact proteins occurs in adenosine-homocysteine endothelial cell apoptosis. Focal adhesion contact disruption induced by adenosine-homocysteine is independent of PTPase or caspase activation. These studies demonstrate that disruption of focal adhesion contacts is an early, but not an irrevocable, event in endothelial cell apoptosis. cell biology; structural biology; vascular biology ENDOTHELIAL CELL INJURY is a hallmark of vascular injury caused by sepsis or associated with trauma. Apoptosis is a form of endothelial cell injury that controls the removal of cells during development and in response to injury. Evidence for apoptosis has been reported in lungs from patients with acute respiratory distress syndrome by Polunovsky et al. (34) . Endothelial cell apoptosis also occurs in atherosclerosis (5), hyperoxiainduced lung injury (3), progressive pulmonary hypertension (25) , and allograft rejection of heart transplants (41) . Furthermore, apoptosis is the mechanism by which angiogenesis is inhibited by angiostatin and endostatin, peptide inhibitors of neovascularization (8, 11) . Thus the balance between endothelial cell apoptosis and proliferation is crucial in vascular injury and repair and in angiogenesis.
Endothelial cell apoptosis is initiated by extracellular factors and by the loss of cell adhesion to the extracellular matrix (13, 22) . Dawicki et al. (9) and Harrington et al. (19) have demonstrated that extracellular ATP or adenosine in concentrations of 100 M causes endothelial cell apoptosis as assessed by DNA ladder formation, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling, and tritiated thymidine release. These elevated levels of ATP or adenosine may occur in vivo during exocytotic release of nucleotides from stimulated platelet granules, by cytolytic release from cells undergoing necrosis, or from endothelial cells by means of membrane transporters (12) . Apoptosis requires ectonucleotidasemediated hydrolysis of extracellular ATP, with the subsequent uptake of adenosine into endothelial cells (9) . Adenosine-induced apoptosis was potentiated by homocysteine and was mimicked by inhibitors of S-adenosyl-L-homocysteine hydrolase (38) . An additional inhibitor study (38) indicated that purinergic receptors, adenosine deaminase, and adenosine kinase activity were not involved in extracellular ATP-induced apoptosis.
Focal adhesion complexes are protein aggregates linking actin filaments to the cytoplasmic domain of integrins. Disruption of cell-substratum association has been reported to cause apoptosis of anchoragedependent cells such as endothelial cells (30, 35) . Focal adhesion complexes consist of 1) heterodimeric integrin proteins; 2) the tyrosine kinases Src and focal adhesion kinase (FAK); 3) actin-binding structural proteins such as vinculin, talin, and ␣-actinin; and 4) the adaptor proteins paxillin and p130
CAS
. Tyrosine phosphorylation of FAK, paxillin, and p130 CAS has been shown to be important for the formation of focal adhesion complexes (reviewed in Refs. 24, 39) .
In the present studies, we determined the effects of adenosine-homocysteine on endothelial cell focal adhe-sion contacts. Immunofluorescence analysis of FAK, paxillin, and vinculin demonstrated disruption of focal adhesion contacts in cells treated with adenosine-homocysteine. In addition, adenosine-homocysteine caused caspase-induced proteolysis of selected protein components of focal adhesion contacts but did not affect the tyrosine phosphorylation level of these proteins. Although caspase inhibition prevented apoptosis, it did not prevent adenosine-homocysteine-induced disruption of focal adhesion contacts. In a previous study, Harrington et al. (19) reported that phosphatase activity is increased early in the course of adenosine-homo- Fig. 1 . Immunofluorescence analysis of focal adhesion complex proteins in adenosine-homocysteine-treated pulmonary artery endothelial cells (PAECs). PAECs were incubated in HEPES buffer with and without 1 mM adenosine or 100 M adenosine-100 M homocysteine for 4 h. The cells were immunofluorescently stained for focal adhesion complex-associated proteins focal adhesion kinase (FAK; A), paxillin (B), or vinculin (C) and visualized with laser scanning confocal microscopy. Arrows, representative focal adhesion complexes immunofluorescently stained for respective proteins. Images are representative of 4 independently performed experiments.
cysteine-induced apoptosis and that phosphatase inhibitors blunt adenosine-homocysteine-induced apoptosis. Because phosphorylation has been found to be crucial to the maintenance of normal interactions between protein components of focal adhesion contacts, we determined the effects of the phosphatase inhibitor sodium orthovanadate (Na 3 VO 4 ) on adenosine-homocysteine-induced disruption of focal adhesion contacts and on caspase-induced proteolysis of FAK, paxillin, and p130 CAS . We found that the phosphatase inhibitor did not prevent adenosine-homocysteine-induced disruption of focal adhesion contacts but that it did inhibit caspase activation; FAK, paxillin, and p130 CAS proteolysis; and apoptosis. These results indicate that disruption of focal adhesion contacts is an early event in adenosine-homocysteine-induced endothelial cell apoptosis and that phosphatase action is critical in precipitating caspase-induced proteolysis.
MATERIALS AND METHODS
Cell lines and reagents. Endothelial cells were obtained from bovine main pulmonary arteries (PAECs) as previously described (9) .
Adenosine, homocysteine, Na 3 VO 4 , and 7-amino-4-methylcoumarin (AMC) were purchased from Sigma. Antibodies directed against vinculin and paxillin were obtained from Sigma, and the p130 CAS antibody was purchased from Transduction Laboratories. FAK antibodies were purchased from Santa Cruz Biotechnology and Transduction Laboratories. The phosphotyrosine antibody PY99 was obtained from Santa Cruz Biotechnology. Protein G Sepharose was obtained from Pierce. Immunoprecipitations and immunoblot analysis. PAECs were scraped and lysed in FAK buffer (50 mM Tris-Cl, pH 7.5, 250 mM NaCl, 0.5% Nonidet P-40, 10% glycerol, 5 mM EDTA, 50 mM NaF, 500 M Na 3 VO 4 , 10 mM ␤-glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 20 g/ml of leupeptin, and 20 g/ml of aprotinin) as previously described (28) . Insoluble cellular debris was removed by centrifugation at 15,000 g for 10 min at 4°C. Protein determinations were performed on the cleared cell lysates.
For immunoprecipitations, 250 g of cell lysate were incubated with 1 g of antibody with shaking at 4°C for 1 h. The immunocomplexes were captured with protein G agarose.
Immunoprecipitates were washed twice with FAK buffer and suspended in Laemmli buffer. The proteins were resolved on SDS-PAGE and transferred to Immobilon-P membranes supplied by Millipore. Immunoblot analyses were performed as previously described (18) .
Immunofluorescent staining of PAECs. PAECs grown on coverslips were rinsed with HEPES buffer and then incubated for 4 h under the indicated incubation conditions. The cells were washed once with PBS, fixed with 4% paraformaldehyde, and rendered permeable with 0.1% Triton X-100 in 0.1% sodium citrate. The cells were then incubated with the primary antibodies in a PBS-5% serum solution for 1 h at 37°C. The cells were washed and then incubated with the fluorescently tagged secondary antibody in PBS-serum solution for 1 h at 37°C. The cells were washed with PBS, and the coverslips were placed facedown on a slide with antifade solution (5% n-propyl gallate, 0.25% 1,4-diazabicyclo[2.2.2]-octane, and 0.0025% 2,5-diphenyl-1,3,4-oxadiazole in glycerol). Images were viewed and recorded with a laser scanning confocal microscope.
DNA fragmentation assay. PAECs were cultured in sixwell dishes. Fragmented DNA was detected as previously described (38) .
Assay of caspase activity. PAECs were harvested, and the washed pellets were resuspended in caspase lysis buffer (10 mM HEPES, pH 7.5, 40 mM ␤-glycerophosphate, 50 mM NaCl, 2 mM MgCl 2 , and 5 mM EGTA) (43) . The cells were lysed with freeze-thaw cycles, and insoluble cellular debris was removed by centrifugation. Caspase activity was measured by incubating 25 g of cell lysate with 50 M Ac-DEVD-AMC in Asp-Glu-Val-Asp-ase (DEVDase) buffer (20 mM HEPES, pH 7.5, 10% glycerol, and 2 mM dithiothreitol) (21) for 1 h at 37°C. Caspase activity was quantitated as the release of the fluorescent conjugate (AMC) from the peptide Statistical analysis. Data are presented as means Ϯ SE. Analysis of variance followed by the least significant difference was used to analyze differences among groups. Differences among means were considered significant when P Ͻ 0.05.
RESULTS

Adenosine-homocysteine induced endothelial cell focal adhesion complex disruption and degradation but not dephosphorylation.
We investigated whether adenosine-induced endothelial cell apoptosis is mediated through the disruption of cell-extracellular matrix adhesion complexes. PAECs immunofluorescently stained for the focal adhesion complex proteins FAK, paxillin, and vinculin demonstrated the expression of these proteins at discrete focal adhesion contacts (Fig. 1, A-C , respectively). There were no consistent differences in FAK or paxillin immunofluorescent staining in cells treated with buffer and adenosine or adenosine-homocysteine after 30 min, 1 h, or 2 h (data not shown). Incubation with 1 mM adenosine or 100 M adenosine-100 M homocysteine for 4 h caused disruption of FAK (Fig. 1A) and paxillin (Fig.  1B ) from these focal adhesion contact points, with concomitant redistribution of these proteins in the retracting cells. After 4 h of incubation with 1 mM adenosine or 100 M adenosine-100 M homocysteine, there were fewer discrete focal adhesion complexes, and immunofluorescent staining of FAK and paxillin was more diffusely distributed within the cytoplasmic space. Vinculin remained localized around the cell periphery (Fig. 1C) after any treatment, and fewer discrete focal adhesion complexes were stained.
To determine whether the redistribution of FAK and paxillin from the focal contacts was due to degradation, we next analyzed these proteins by immunoblot analysis at various times after treatment with adenosinehomocysteine. Figure 2 demonstrated time-dependent proteolysis of FAK, paxillin, and p130 CAS after exposure to adenosine or adenosine-homocysteine. Dimin- 
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ished full-length FAK (125-kDa) and paxillin (68-kDa) protein products were noted 8 h after treatment, with an increase in proteolytic products seen (Fig. 2, A and  C, respectively) . Analysis of p130 CAS demonstrated the degradation of the 130-kDa protein as early as 4 h after adenosine or adenosine-homocysteine treatment (Fig.  2E ). Densitometric analyses of the immunoblots demonstrated significantly less full-length FAK, paxillin, and p130
CAS after 8 and 14 h of exposure to adenosinehomocysteine compared with the control levels (Fig. 2,  B, D, and F, respectively) . No significant changes were noted in the protein quantity of vinculin in cell lysates incubated with adenosine or adenosine-homocysteine compared with that in buffer-treated cell lysates (Fig.  2, G and H) . Of note, Fig. 2D reveals a 
The level of tyrosine phosphorylation of focal adhesion contact proteins has been shown to be critical in determining cellular adhesion to the extracellular matrix, apoptosis, and migration (1, 4, 23) . We assessed FAK and paxillin immunoprecipitates for changes in tyrosine phosphorylation by immunoblot analysis with a phosphotyrosine antibody. No significant changes in FAK (Fig. 3, A and B) or paxillin (Fig. 3, C and D) tyrosine phosphorylation levels were noted even after 8 h of exposure to adenosine-homocysteine. Thus it seems that the adenosine-homocysteine-induced focal adhesion contact disruption and proteolysis occurs independently of changes in the state of tyrosine phosphorylation of these protein components.
The role of caspases in adenosine-homocysteine-induced apoptosis. The caspases are a family of proteases involved in the cleavage of cellular substrates, which ultimately leads to apoptosis (42) . To assess the requirement for caspases in adenosine-homocysteine-induced endothelial cell apoptosis and focal adhesion contact disruption, adenosine-homocysteine-treated PAECs were pretreated with 100 M Z-VAD-FMK, a broad-spectrum caspase inhibitor. Adenosine-and adenosine-homocysteine-induced apoptosis were completely blocked in endothelial cells preincubated with Z-VAD-FMK (Fig. 4A) . Analysis of caspase activation demonstrated significantly elevated DEVDase activity in endothelial cells after 4 and 8 h of treatment with adenosine or adenosine-homocysteine (Fig. 4B) , respectively). We assessed whether the Z-VAD-FMK inhibitor was blocking adenosine-and adenosine-homocysteine-induced apoptosis by preventing focal adhesion complex disruption or by cellular proteolysis of the focal adhesion complex proteins. Preincubation of endothelial cells with Z-VAD-FMK did not block cellular retraction or the redistribution of FAK from focal adhesion complexes in adenosine-homocysteine-treated cells (Fig. 5) . Also, cells immunofluorescently stained for paxillin or vinculin demonstrated similar cellular retraction and focal adhesion complex disruption. Similar results were seen in cells treated with adenosine and immunofluorescently stained for FAK, paxillin, or vinculin (data not shown). Next, we compared FAK, paxillin, and p130
CAS protein content in buffer-, adenosine-, or adenosine-homocysteine-incubated endothelial cells that had been either pretreated or not pretreated with the caspase inhibitor. Figure 6 demonstrates that Z-VAD-FMK blocked FAK, paxillin, and p130 CAS proteolysis in endothelial cells treated with adenosine or adenosine-homocysteine for 14 h (P Ͻ 0.05). These results were consistent with the DNA fragmentation experiment and suggest that the degradation of proteins important for focal adhesion contact integrity is required for apoptosis to occur in adenosine-or adenosine-homocysteine-treated PAECs.
The role of protein tyrosine phosphatases in focal adhesion complex disruption. Harrington et al. (19) have demonstrated that treatment of endothelial cells with adenosine enhanced intracellular protein tyrosine phosphatase (PTPase) activity. In addition, Na 3 VO 4 , a PTPase inhibitor, blunted the apoptotic effect of adenosine or adenosine-homocysteine (19). Thus we investigated whether the early event of FAK or paxillin relocalization induced by adenosine or adenosine-homocysteine was dependent on PTPase activity.
The amount of endothelial cell retraction and focal adhesion contact disruption was not significantly different in cells coincubated with Na 3 VO 4 and adenosine-homocysteine for 4 h (Fig. 7D ) compared with adenosine-homocysteine-incubated cells not treated with Na 3 VO 4 (Fig. 7C) . Similar results were seen in cells immunofluorescently labeled with antibodies directed against paxillin or vinculin. Additionally, no significant differences were noted in PAECs coincubated with Na 3 VO 4 and adenosine and immunofluorescently stained for FAK, paxillin, or vinculin (data not shown). Next, we examined whether adenosine-and adenosine-homocysteine-induced FAK, paxillin, and p130 CAS protein degradation was dependent on PTPase activity. PAECs were incubated with adenosine or adenosine-homocysteine in the presence and absence of Na 3 VO 4 . Figure 8 , A and B, demonstrates significantly less proteolysis of FAK, paxillin, and p130 CAS in cells coincubated with Na 3 VO 4 and adenosine for 14 h compared with respective treatments without Na 3 VO 4 (P Ͻ 0.005). Although endothelial cells coincubated with Na 3 VO 4 and adenosine-homocysteine had a diminished level of FAK, paxillin, and p130 CAS proteolysis, the protection was significant for p130 CAS . Coincubation with Na 3 VO 4 also decreased adenosine-and adenosine-homocysteine-induced increases in DEVDase activity (Fig.  8C) . Na 3 VO 4 had no effect on the DEVDase activity of adenosine-homocysteine-treated cell lysates when added during the in vitro caspase assay. These data suggest that adenosine-homocysteine-activated PTPase(s) is required for the initiation of caspase-dependent FAK, paxillin, and p130 CAS proteolysis.
DISCUSSION
Several studies (13, 30, 35, 43) have shown that disruption of cell-extracellular matrix interactions induced apoptosis in adherent cell types. Our results indicate that disruption of focal adhesion complexes is an early event in adenosine-homocysteine-induced apop- tosis, occurring after 4 h of treatment. However, disruption of focal adhesion complexes is not an irrevocable step in the pathway of programmed cell death because agents such as a caspase inhibitor, Z-VAD-FMK, and a PTPase inhibitor, Na 3 VO 4 , did not prevent focal adhesion complex disruption but did inhibit adenosine-homocysteine-induced DNA fragmentation; caspase activation; and FAK, paxillin, and p130 CAS proteolysis.
Dawicki et al. (9) have previously shown that extracellular ATP or adenosine in a concentration of 100 M causes endothelial cell apoptosis. Sources of extracellular ATP and adenosine release include exocytosis in platelet granules, cytolytic release from cells undergoing necrosis, and noncytolytic release from endothelial cells by means of membrane transporters. The intracellular concentration of ATP in most cells is 3-5 mM (15) . Thus cytolytic release due to rhabdomyolysis and hemolysis or platelet degranulation (15) can be a significant source of extracellular ATP. The action of endothelial and blood cell surface ectonucleotidases on ATP generates adenosine. Thus the concentration of adenosine used in these studies is achievable in vivo.
Homocysteinemia is associated with arterial and venous thrombosis (17) and atherosclerosis (29) . The mechanism(s) by which homocysteine causes vascular injury is not known, but studies have shown that homocysteine injures cultured endothelial cells by a prooxidant effect (40) and that exposure to homocysteine changes endothelial cell gene expression (7, 27, 32) . However, these effects required millimolar concentrations of homocysteine. Plasma homocysteine levels of 20-30 M are associated with vascular injury in humans as assessed by endothelial cell detachment (20) . Levels Ͼ 12 M are associated with vascular disease (29) . Genetic absence of cystathione ␤-synthase activity, a cause of homocysteinuria, results in plasma levels Ͼ 100 M (26). Thus the concentration of homocysteine that we used in these studies is within the range associated with disease in vivo.
Adenosine-homocysteine-induced disruption of focal adhesion complexes was followed at 8-14 h by proteolysis of FAK, paxillin, and p130 CAS , focal adhesion complex protein components. This proteolysis was prevented by the broad-spectrum caspase inhibitor Z-VAD-FMK, which was also effective in preventing CAS degradation. PAECs were incubated with buffer, adenosine, or adenosine-homocysteine. In parallel, PAECs were treated as described in Fig. 5 and coincubated with Z-VAD-FMK. Cell lysates were collected from cells incubated as described in adenosine-homocysteine-induced apoptosis. Others have described relocalization of FAK from focal adhesion complexes during apoptosis (43) and caspase-induced proteolysis of FAK (2, 14, 28, 43, 45) and p130 CAS (2) in various cell types and models of apoptosis. In these studies, we demonstrated caspase-induced proteolysis of FAK, paxillin, and p130 CAS but not of vinculin. The reason for the sparing of vinculin is not clear but may relate to a relatively protected site in the cellular cytoskeleton.
In addition, we have demonstrated that the PTPase inhibitor Na 3 VO 4 prevented both caspase activation and caspase-induced proteolysis of protein components of focal adhesion complexes. In a previous study, Harrington et al. (19) have shown that increased PTPase activity occurs within 1 h of exposure of endothelial cells to adenosine-homocysteine, that Na 3 VO 4 is an effective PTPase inhibitor in the concentration used in this study, and that Na 3 VO 4 inhibits adenosine-homocysteine-induced apoptosis.
The level of tyrosine phosphorylation of the components of focal adhesion complexes has been shown to be important for regulating the assembly, and possibly the disassembly, of focal adhesion contacts. On activation, FAK autophosphorylates Tyr 397 , creating a binding site for the SH2 domain of the Src family kinases Src (16) . Binding of Src, in turn, results in the further tyrosine phosphorylation of FAK, paxillin, tensin, and p130 CAS (37, 44) . FAK directly interacts with paxillin and p130 CAS (33) . In addition, phosphorylation of FAK on Tyr 925 results in the association with Grb2 and activation of the Ras/mitogen-activated protein kinase signal transduction pathway (16) . Similar interactions have been demonstrated for paxillin and p130 CAS (1, 4, 31) . The balance between phosphorylation and dephosphorylation of focal adhesion complex components is important for the maintenance of cell-extracellular matrix interactions and in intracellular signal transduction.
PTPase inhibitors, including Na 3 VO 4 , have been shown to enhance phosphorylation of FAK and paxillin in endothelial cells (10, 46) and fibroblasts (36) . Thus we considered the possibility that FAK dephosphorylation might be the mechanism of adenosine-homocysteine-induced disruption of focal adhesion complexes. However, the results of this study demonstrate that the disruption of focal adhesion complexes was not prevented by the PTPase inhibitor and that tyrosine dephosphorylation of FAK or paxillin is not caused by adenosine-homocysteine. Thus the mechanism of Na 3 VO 4 inhibition of adenosine-homocysteine-induced apoptosis does not involve changes in tyrosine phos- phorylation of FAK or paxillin. The dependence of caspase activation, proteolysis, and apoptosis on PTPase activity suggests that tyrosine dephosphorylation is crucial in the activation of caspases. Addition of Na 3 VO 4 did block caspase activation, suggesting a possible requirement for PTPase-dependent DEVDase activation. Cardone et al. (6) have demonstrated that procaspase-9 is serine phosphorylated by Akt, a posttranslational modification that conferred inactivation of this caspase. However, there have been no studies describing the caspase tyrosine phosphorylation level as being crucial for the activation of these proteases. Thus it is probable that PTPase(s) does not act directly on the caspases but indirectly on the upstream targets, which then mediate the activation of caspases.
In vitro assays have demonstrated FAK to be a suitable substrate for caspase-3, caspase-6, caspase-7, and caspase-8 (14, 28, 45) . It is possible that adenosinehomocysteine produces tyrosine, serine, or threonine dephosphorylation of other focal adhesion complex protein components, causing diminished protein-protein interactions between the focal adhesion complex pro- CAS proteolysis and DEVDase activity. A: PAECs were incubated with buffer, adenosine, or adenosine-homocysteine. In parallel, PAECs were treated as described in Fig. 7 and coincubated with Na 3 VO 4 . Cell lysates were collected from cells incubated as described in Fig. 2 teins. The adenosine-homocysteine-induced alteration(s) of the focal adhesion complex protein(s) may, in turn, expose protein domains containing consensus sequences recognized and proteolysed by the caspases. Studies (2, 43) have shown that the levels of tyrosine-phosphorylated FAK and paxillin diminish on induction of apoptosis in other models. However, our results indicate that tyrosine dephosphorylation of FAK and paxillin does not occur in endothelial cells exposed to adenosine-homocysteine. Decreased interactions between FAK and paxillin, vinculin, or p130
CAS have been noted in endothelial cells after apoptosis induced by growth factor deprivation (28) and lipopolysaccharide (2); thus it is possible that this is occurring in our system.
While this manuscript was in preparation, another group (43) demonstrated that FAK dephosphorylation and loss of focal adhesion contacts preceded caspaseinduced FAK proteolysis in renal epithelial cells exposed to a nephrotoxicant. Van de Water et al. (43) showed that PTPase activity was not required for caspase-dependent FAK proteolysis or epithelial cell apoptosis. Also, that study presented data in which apoptosis, focal adhesion complex disruption, and cell detachment occurred in the absence of PTPase activity. We also show that focal adhesion complex disruption is not dependent on PTPase or caspase activation. However, in contrast to the van de Water et al. study, we show a requirement for PTPase for the complete induction of endothelial cell caspase activation, FAK, paxillin, and p130 CAS proteolysis and DNA degradation on exposure to adenosine-homocysteine. Thus it is likely that multiple pathways are utilized for the transmission of apoptotic signals, which both share common steps but are also divergent depending on the apoptosis-inducing agent and cell type.
In summary, these studies demonstrate that disruption of focal adhesion complexes is an early event in programmed cell death and that caspase-induced proteolysis and apoptosis are dependent on PTPase activation. There appear to be at least three sequential stages in adenosine-homocysteine-induced apoptosis: 1) focal adhesion complex disruption, 2) caspase-induced proteolysis, and 3) DNA fragmentation. Although activation of an as yet unknown PTPase(s) occurs early in this sequence, it is not required for focal adhesion complex disruption.
